Keyword,Category
MOMENTUM,Competitor asset
BOREAS,Key studies
TRANSFORM-2,Key studies
TRANSFORM-1,Key studies
TRANSFORM,Competitor asset
JAKARTA,Key studies
DISC-0974,Competitor assets
INCB000928,Competitor assets
INCB000928,Competitor asset
Elritercept,Competitor assets
Elritercept,Competitor asset
PXS-5505,Competitor asset
PXS-5505,Competitor assets
Bomedemstat,Competitor asset
Bomedemstat,Competitor assets
Luspatercept,Competitor assets
TP-3654,Competitor asset
Nuvisertib,Competitor assets
Tagraxofusp,Competitor asset
Tagraxofusp,Competitor assets
Selinexor,Competitor asset
PRM-151,Competitor assets
PRM-151,Competitor asset
OPN-2853,Competitor asset
Parsaclisib,Competitor asset
LCL-161,Competitor asset
Jaktinib,Competitor assets
INCB057643,Competitor asset
Fedratinib,Competitor asset
Pelabresib,Competitor assets
Pelabresib,Competitor asset
BMS-986158,Competitor asset
AVID200,Competitor assets
AVID200,Competitor asset
Navtemadlin,Competitor asset
Navtemadlin,Competitor assets
Pacritinib,Competitor asset
Navitoclax,Competitor asset
Navitoclax,Competitor assets
Momelotinib,GSK product
Ruxolitinib,Competitor assets
Alisertib,Competitor asset
TGFb ligand trap,Drug Class
LSD1 inhibitor,Drug Class
JAK inhibitor,Key studies
JAK inhibitor,Drug Class
PIM kinase inhibitor,Drug Class
BET inhibitor,Key studies
BET inhibitor,Drug Class
MDM2 inhibitor,Drug Class
SINE,Drug Class
PI3K inhibitor,Drug Class
ACVR1,Drug Class
Dual BET/p300 inhibitor,Drug Class
Anti-hemojuvelin Ab,Drug Class
LOX inhibitor,Drug Class
ACVR inhibitor,Drug Class
ACVR1i,Drug Class
JAK2i,Drug Class
JAK1i,Drug Class
RESTORE,Key studies
IMPOVEMF,Key studies
IMPACTMF,Key studies
PERSIST-1,Key studies
EXPAND,Key studies
COMFORT-2,Key studies
COMFORT-1,Key studies
MPN-RC 118,Key studies
INDEPENDENCE,Key studies
2013-004476-36,Key studies
LIMBER,Key studies
FREEDOM,Key studies
MANIFEST-2,Key studies
PACIFICA,Key studies
MANIFEST,Key studies
REFINE,Key studies
PERSIST-2,Key studies
SIMPLIFY2,Key studies
SIMPLIFY1,Key studies
GS-US-352-1672,Key studies
NEO2734,Competitor asset
ZGJAK016,Competitor asset
OB756,Competitor asset
KT-253,Competitor asset
